Abstract
Background and Aims : Familial hypercholesterolemia (FH) is an autosomal codominant lipid metabolism disorder mostly caused by defects of a low-density lipoprotein (LDL) receptor gene. This condition results in lifelong elevation of plasmatic LDL-cholesterol (LDL-C) levels, followed by premature atherosclerosis and an increase in cardiovascular risk. Management of women suffering from the homozygous form of FH (HoFH) poses difficult demands on physicians, regarding specific phases of their patients' lives.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
